close

Clinical Trials

1 207 208 209 210 211 220
Number of results: 4389

PDF print is not allowed for data more than 300.Please search above for fewer data.

Date Product Disease Phase Company Therapeutic area
2011-09-27 LB03002 (once-a-week, sustained release recombinant human growth hormone (hGH)) growth hormone deficiency 3 Biopartners (Switzerland) LG Life Sciences (Korea) Hormonal diseases - Endocrine diseases
2011-09-26 AP214

renal protection in cardiac surgery

2b Action Pharma (Denmark) Cardiovascular diseases - Renal diseases - Kidney diseases
2011-09-26 Afinitor® (everolimus) breast cancer 3 Novartis (Switzerland) Cancer Oncology
2011-09-25 QTI571 (imatinib) pulmonary arterial hypertension 3 Novartis (Switzerland) Rare diseases - Cardiovascular diseases - Autoimmune diseases
2011-09-22 BIBF 1120*

idiopathic pulmonary fibrosis

2 Boehringer Ingelheim (Germany) Lung diseases
2011-09-21 tiotropium plus olodaterol

chronic obstructive pulmonary disease (COPD)

3 Boehringer Ingelheim (Germany) Respiratory diseases
2011-09-21 NI-0801 primary biliary cirrhosis 2 NovImmune (Switzerland) Rare diseases Autoimmune diseases
2011-09-20 budesonide MMX® induction of remission of mild or moderate active ulcerative colitis 3 Cosmo Pharmaceutical (Italy) Santarus (USA) Inflammatory diseases - Autoimmune diseases
2011-09-19 TrasGEX™ breast cancer 1 Glycotope (Germany) Cancer Oncology
2011-09-19 Epi proColon® 2.0 (colorectal cancer blood test) colorectal cancer detection validation study Epigenomics (Germany-USA) Cancer - Oncology
2011-09-19 PRC-4016 combined dyslipidemia 1 Pronova BioPharma (Norway) Metabolic diseases Cardiovascular diseases
2011-09-19 ChondroCelect® symptomatic cartilage defects of the knee follow-up Tigenix (Belgium) Bone diseases
2011-09-16 Ixiaro® Japanese Encephalitis 3 Intercell (Austria) Biological E. Ltd (India) Infectious diseases
2011-09-16 ACZ885 (canakinumab) systemic juvenile idiopathic arthritis (SJIA) 3 Novartis (Switzerland) Autoimmune diseases - Rare diseases
2011-09-15 Px-102

NASH (non-alcoholic steatohepatitis) and other liver diseases

1 Phenex Pharmaceuticals (Germany) Metabolic diseases - Liver diseases
2011-09-15 AG013 prevention of oral mucositis in head and neck cancer patients receiving chemo-induction therapy 1b Actogenix (Belgium) Cancer Oncology
2011-09-14 masitinib asthma 3 AB Science (France) Allergic diseases - Inflammatory diseases - Respiratory diseases
2011-09-13 ACP-001 growth hormone deficiency 2 Ascendis Pharma (USA-Denmark) Hormonal diseases - Endocrine diseases
2011-09-12 GFT505

NASH (non-alcoholic steatohepatitis

NAFLD (non-alcoholic fatty liver disease)

preclinical Genfit (France) Liver diseases - Metabolic diseases
2011-09-07 MG01CI (extended release formulation of Metadoxine (pyridoxol L-2-pyrrolidone-5-carboxylate)

attention deficit hyperactivity disorder (ADHD)

2 Teva Pharmaceutical Industries (Israel) Alcobra (Israel) CNS diseases - Neurological diseases